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Natural killer (NK) cells are a unique lymphocyte lineage with remarkable agility in the 
rapid destruction of virus-infected cells. They are also the most poorly understood class 
of lymphocyte. A spectrum of activating and inhibitory receptors at the NK cell surface 
leads to an unusual and difficult-to-study mechanism of cellular recognition, as well as a 
very high capacity for diversity at the single-cell level. Here, we review the evidence for 
the role of NK cells in the earliest stage of human viral infection, and in its prevention. 
We argue that single-cell diversity is a logical evolutionary adaptation for their position in 
the immune response and contributes to their ability to kill virus-infected cells. Finally, we 
look to the future, where emerging single-cell technologies will enable a new generation 
of rigorous and clinically relevant studies on NK cells accounting for all of their unique 
and diverse characteristics.
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Natural killer (NK) cells were discovered in 1975 (1, 2) on the basis of their ability to selectively lyse 
leukemic cell lines. Originally called “null cells” because they were believed not to express cell surface 
receptors, they were eventually recognized as a third lineage of lymphocyte distinct from T and B 
cells (3). Recently, the role of NK cells as the founding member of a growing group known as innate 
lymphoid cells has also been appreciated (4).
Natural killer cells are a unique lineage with remarkable agility. They rapidly detect and destroy 
virus-infected, malignant, and stressed cells (5, 6). They are also the most poorly understood class of 
lymphocyte, due in part to their unusual and difficult-to-study mechanism of cellular recognition. 
The NK cell surface contains a spectrum of activating and inhibitory receptors (7). It is the integra-
tion and balance of signals from these receptors that determine a cell’s activation status (8).
This array of receptors also generates the opportunity for vast diversity in the NK repertoire. 
Examination of this diversity has been limited: studying a large number of parameters on a single 
cell is technologically challenging. Yet, it may be a critical functional feature of the NK cell repertoire.
In many of the ways in which immune cells are conventionally categorized, NK cells are inter-
mediates. They borrow, share, and combine functional features of other cell types to form their own 
recognition paradigm. This helps to explain their enigmatic nature and argues that they occupy a 
unique evolutionary niche. Here, we review this recognition paradigm, with a focus on NK responses 
to viruses, and argue that single-cell diversity enhances their ability to fulfill this “middleman” role. 
We also discuss current and future studies, where single-cell technology will allow a much more 
detailed and nuanced dissection of the roles and promise of NK cells in the antiviral response.
FiGURe 1 | Schematic of nK cells as immune intermediates in cell 
lineage, ratio of receptors to potential pathogens, and cellular 
half-life. Half-life values are approximated based on published data (9–15).
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nK CeLLS HAve LiFeTiMeS OF 
inTeRMeDiATe LenGTH
In comparison to their classic innate and adaptive counterparts, 
NK cells take an intermediate position in estimates of cellular 
lifetime (Figure 1). In deuterium incorporation studies, human T 
cells have the longest estimated leukocyte half-lives, at 1–8 years 
for naive T cells and 1–12 months for memory T cells (9, 10). 
Estimated half-lives for CD27− naive B cells, CD27+ memory B 
cells, and plasma cells are somewhat more limited, at 22, 11, and 
40 days, respectively (11, 12). For NK cells, half-lives are shorter, 
estimated at 7 days (13). Yet, they still outlast their innate coun-
terparts, with monocytes’ half-lives estimated at 71  h (14) and 
neutrophils’ reported between 5 and 90 h (15). It is important to 
note that only actively dividing cells incorporate deuterium, and 
thus these studies may not account for long-lived, non-dividing 
cells. They are also based entirely in peripheral blood; cell kinetics 
in tissues may follow completely different patterns. Yet, with these 
caveats in mind, these data suggest that NK cells fall midway on 
the spectrum of cellular lifetime. These estimates may also serve 
as a reasonable proxy for the amount of time they require to 
respond to viral infection.
nK CeLLS ARe inTeRMeDiATe in THeiR 
MeCHAniSM OF ReCOGniTiOn
Cells of the innate system typically recognize non-self entities 
through specific receptor–ligand interactions. The toll-like 
receptor (TLR) system and other pattern recognition receptors, 
including RIG-I-like receptors, NOD-like receptors, and C-type 
lectin receptors, are designed to recognize specific features of 
pathogens or other danger signals (16, 17). Recognition is fast 
and digital, having only on/off states. It triggers phagocytosis, the 
release of inflammatory cytokines, and regulation of downstream 
adaptive responses. With 10 TLRs identified in humans to date 
and other pattern recognition receptor classes in the same order 
of magnitude or fewer, the innate paradigm is characterized by a 
low ratio of receptors per potential pathogen (Figure 1).
While the innate system has evolved to recognize broad 
classes of pathogens through a limited set of receptors, the 
adaptive system takes the converse approach of employing a 
broad set of receptors that each recognize a very limited set of 
pathogens. In T and B cells, V(D)J recombination forms special-
ized, antigen-specific receptors. When triggered in combination 
with costimulation, these receptors initiate proliferation, cyto-
toxicity, production of antibodies, and release of cytokines. The 
total potential diversity of the human T cell receptor (TCR) is 
estimated at 1015–1020 sequences (18, 19). The adaptive system is 
therefore characterized by a high ratio of receptors to potential 
pathogens (Figure 1).
Natural killer cells take cues from both extremes. They 
express a spectrum of receptors, which can be either activating 
or inhibitory, through which they integrate signals to determine 
their activation status. These include killer immunoglobulin-like 
receptors (KIR), C-type lectin-like receptors, signaling lympho-
cyte activation molecule (SLAM) family receptors, and natural 
cytotoxicity receptors, among others (20). Unlike other cell types, 
NK activation is analog: increased activating or decreased inhibi-
tory signals can tip the balance toward activation, but typically no 
specific receptor–ligand interaction is required. In fact, CD16 is 
the only receptor that has been shown to be capable of activating 
NK cells independently (21). In addition, NK cells are the only 
lymphocytes that can be activated purely through soluble signals. 
Proliferation, cytotoxicity, and a migratory phenotype can be 
induced by cytokines alone without specific antigen signal or 
presentation (22, 23).
Thus, the lifespan of NK cells, their mechanism of recognition, 
and in addition, recent evidence for memory in NK cell responses 
(24–26) suggest that they play a truly intermediate role between 
innate and adaptive responses (Figure 1).
SinGLe-CeLL DiveRSiTY: A LOGiCAL 
ADAPTATiOn FOR MiDDLeMen
The diversity in a T cell or B cell repertoire is captured in a single 
receptor. NK cells, by contrast, are diverse at a single-cell level. 
Each cell expresses a combination of receptors drawn from a vast 
potential pool. Our early estimates, based on 28 markers, place 
the total number of combinations in human peripheral blood 
on the order of 104 (27). With deeper sampling, measurement 
in a greater diversity of tissues, and improvements in technology 
allowing increased dimensionality, this estimate will certainly 
increase. A modest increase to measuring 40 NK cell receptors 
on a single cell would yield 1012 theoretical combinations. In 
comparison, T cells have been estimated to have 2.5 × 107 unique 
TABLe 1 | evidence for the role of nK cells in the prevention of viral acquisition.
virus Study population Major finding Total sample size Reference
HSV-1 HSV-1-infected adults The presence of KIR2DL2 or KIR2DS2 by PCR was associated with 
progression to symptomatic, as compared to asymptomatic, HSV-1 
infection
131 (36)
HCV HCV patients and healthy adult  
controls
RNA+ HCV patients had increased presence of KIR2DL2 or KIR2DS2 
by PCR compared with self-limited RNA− HCV patients
596 (37)
Acutely infected HCV patients and 
healthy adults
NK cells from acutely infected HCV patients produced more IFN-γ 
and degranulated more than NK cells from healthy controls
39, 44 (38, 39)
People who inject drugs with or 
without seroconversion or spontaneous 
clearance
Relative to chronically infected individuals, homozygosity for KIR2DL3 
and its ligand HLA-C1 was more frequent in exposed seronegative 
individuals or those who spontaneously cleared the virus
1037, 305 (40, 41)
Acute and chronic HCV patients, 
patients who naturally resolved 
infection, and healthy controls
During acute infection, fewer NKp30+, NKp46+, CD161+, and 
NKG2D+ NK cells were present in individuals who subsequently 
cleared than those who became chronically infected
57 (42)
People who inject drugs with or without 
seroconversion, healthy adults
Higher anti-K562 cytotoxicity and higher NKp30 expression detected 
in exposed uninfected individuals
33 (43)
People who inject drugs with or without 
seroconversion, healthy adults
Presence of KIR2DL3+NKG2A− NK cells was associated with 
protection from productive HCV infection
114 (44)
Chikungunya Chikungunya patients, healthy  
controls
NK cells from acutely infected chikungunya patients become 
activated and expand early in infection
55, 143 (45, 46) 
EBV EBV-college students Increased CD56dimNKG2A+CD57+NK cells detected in peripheral 
blood during acute infectious mononucleosis
18 (47)
CMV Solid organ transplant recipients, bone 
marrow transplant recipients
CD57+NKG2Chi NK cells preferentially respond during CMV 
reactivation
140, 65 (48, 49)
HIV South African women: cases acquired 
HIV, matched controls did not
Decreased pre-infection IFN-γ responses to autologous infected 
CD4+ T cells were associated with increased acquisition risk
60 (50)
South African women: cases acquired 
HIV, matched controls did not
Increased pre-infection NK activation (higher HLA-DR and lower 
CD38) was associated with increased acquisition risk
81 (51)
Exposed uninfected intravascular drug 
users, seroconverters before  
or after seroconversion,  
unexposed controls
NK cells from exposed uninfected intravascular drug users showed 
greater lytic activity and produced more cytokines in response to 
cell lines than unexposed controls or seroconverters before or after 
seroconversion
75 (52)
Kenyan women: cases acquired HIV, 
matched controls did not
Increased pre-infection NK diversity correlated with increased 
acquisition risk
36 (53)
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TCR sequences in humans (28). As mentioned above, their total 
potential diversity is estimated at 1015–1020 sequences (18, 19).
Thus, both theoretically and empirically, NK cells are highly 
diverse, but several orders of magnitude less so than T cells. 
Yet, T cell (and B cell) diversity is rigid, modifiable primarily by 
population-level expansion and contraction. The antigen-specific 
TCR or BCR, while optimizable via somatic hypermutation or 
affinity maturation, is pre-formed following exit from the bone 
marrow or thymus. For adaptive cells tasked with developing 
a slow but reliable memory response, it is a logical tradeoff to 
expend energy on selecting a vast but inflexible repertoire.
Natural killer diversity compensates for its lack of breadth with 
its flexibility, a logical evolutionary adaptation for cells that must 
act quickly. NK diversity can be modulated with vastly more agil-
ity and at many different levels. NK cells can up- or downregulate 
receptors to adjust repertoire diversity at the timescale of cellular 
processes rather than cellular division (29), one cell at a time 
rather than by population. Many NK cell receptors, especially the 
KIRs, are defined by vast population-level genetic diversity (30). 
This can be compounded at multiple levels: selective transcription 
and translation, post-translational modifications, protein traf-
ficking, cytokine signaling, cell–cell interactions, and epigenetic 
modifications (31–33). NK cell diversity is thus much more 
responsive to both genetic and environmental determinants. This 
responsiveness may prove to be a critical feature for maintaining 
flexibility in the earliest lymphocyte response.
nK CeLLS in viRAL SUSCePTiBiLiTY
Because of their uniquely centered position in the immune 
system, their associations with improved control of viral infec-
tions (34), and recent evidence of their potential for a memory 
response, much interest has been focused on whether NK cells 
can be harnessed as part of a strategy for the initial prevention of 
viral infection (Table 1). Prevention is an especially significant 
goal for chronic incurable diseases, such as HIV. Mechanisms 
by which NK cells could successfully prevent viral infections 
include localization of NK cells to barriers of viral entry, efficient 
cytotoxicity, swift production of IFN-γ for recruitment and 
activation of downstream adaptive responses, and production of 
β-chemokines that can block viral entry (35).
Directly studying the immune correlates of human viral sus-
ceptibility is challenging. It requires either tracking uninfected 
people over long periods of time, a difficult logistical hurdle, or 
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infecting people in a controlled environment, an ethical quan-
dary. Several approaches have therefore been used to provide 
indirect evidence for the importance of NK cells in human viral 
susceptibility.
First, much has been learned from studies of immunodeficient 
subjects with deficiencies in NK cell frequency or function. In 
addition to several mutations known to exert their effects on NK 
cells in relative isolation, at least 46 primary immunodeficiencies 
are also associated with NK cell defects. These subjects’ overarch-
ing and unifying feature is the unusual susceptibility to herpesvi-
ruses (54), especially HSV-1, EBV, VSV, and HPV. These findings 
suggest that NK cells play a non-redundant role in preventing the 
establishment of these infections.
Second, many studies identify NK-relevant genetic correlates 
associated with disease-afflicted individuals versus healthy 
controls. These retrospective studies are not direct measures 
of acquisition probability, but do provide evidence of possible 
associations. The presence of KIR2DL2 and KIR2DS2 has been 
associated with progression to infection in both HSV-1 (36) and 
HCV (37).
A third approach has been to examine the characteristics and 
strength of NK responses during acute infection and sometimes 
draw correlations with disease outcome. In these studies, blood is 
typically drawn at the time of clinical presentation. This approach 
provides an imprecise approximation of the earliest events in 
infection but has the distinct advantage of allowing functional 
immunological studies. These studies have identified several 
early-stage markers of NK cell activation in viral infection. In 
HCV, KIR2DL3 in combination with HLA-C1 at both the genetic 
and cellular level has emerged as an important correlate of protec-
tion from infection (40, 41, 44). In addition, NKG2C+ NK cells 
have been shown to specifically respond to CMV reactivation in 
transplant recipients (48, 49).
A fourth type of study measures the immune activity of 
individuals who remain seronegative despite behavior that grants 
high probability of viral exposure, providing clues as to what is 
assumed to be an effective protective immune response. The 
primary issue with these studies is that this form of resistance 
is not fully understood, and the highly exposed immune state 
of these individuals (typically sex workers or people who inject 
drugs) may not be representative of other routes of acquisition.
Finally, a handful of studies, so far only in the HIV field, 
have enrolled and tracked large cohorts at risk of infection, 
banking blood samples before and after detection of infection, 
and performed functional studies on pre-infection samples. 
While impressive in scope, their conclusions have unfortunately 
not been entirely clear. While the ability of NK cells to secrete 
IFN-γ in response to HIV-infected cells was associated with 
decreased risk of infection (50), generalized NK cell activation 
(as measured primarily by expression of CD38 and/or HLA-DR) 
was associated with increased risk of HIV acquisition (51). 
Thus, depending on its nature, NK cell activation has been both 
positively and negatively associated with increased risk of HIV 
acquisition.
Our recent study took a different approach. In addition to 
measuring activation status and individual markers, we calculated 
a diversity score for the NK cell repertoire of each donor before 
the onset of HIV infection. We showed that no single marker 
was predictive of HIV acquisition risk, but that higher NK cell 
diversity was associated with increased risk of HIV acquisition in 
a cohort of Kenyan women (53). This raises the intriguing pos-
sibility that NK repertoire diversification is detrimental to the NK 
cell response. As it represents an apparent state of ramification 
and inflexibility, high NK diversity may signal a higher risk of 
exposure and/or less resistant state of immunity.
All of these studies involve clinical cohorts that are limited 
in size. The brute-force approach of obtaining additional valida-
tion cohorts will be a necessary step in bolstering these results. 
However, targeted single-cell approaches that incorporate leading 
edge technologies and account for the increasingly appreciated 
diversity of the NK repertoire are in rapid development. These 
approaches hold great promise in bringing a new level of under-
standing to the role of NK cells in viral susceptibility.
new nK CeLL-FOCUSeD APPROACHeS 
in SinGLe-CeLL TeCHnOLOGY
Innovative microchip-based approaches have begun to uncover 
broad diversity in single-cell function. In a single-cell tracking 
system, the distribution of average kill times on a per-NK-cell basis 
was skewed, with a few “serial killers” performing the majority of 
the killing (55, 56). Furthermore, increased cytotoxicity has been 
shown to result from simultaneous interaction of NK cells with 
multiple targets (57) as well as IL-2 activation (23). NKG2A+ NK 
cells have also been shown to be superior to NKG2A− NK cells in 
terms of dynamic migration, conjugation, spreading, and killing. 
“Serial killers” were also more common in this population (58).
Natural killer cell-focused mass cytometry, which has been 
pioneered by our group and others (27, 53, 59, 60), also holds 
great promise in further defining the role of NK diversity in viral 
acquisition at a single-cell level. This technology will be especially 
powerful when used in conjunction with humanized mice (61), 
presenting the next frontier in detailed tracking of all stages of the 
human NK cell response to viral infection.
Furthermore, single-cell dissection of functional diversity, 
especially in the context of a viral response, will greatly improve 
understanding of the processes by which NK cells may contribute 
to the prevention of infection. The generation of more single-cell 
data will also help to alleviate the statistical issues associated with 
small sample sizes in clinical studies.
Many questions remain about the functional consequences of 
NK cell diversity. Does a differentiated NK cell respond better 
and faster when re-encountering its initial stimulus? What is the 
spectrum of antigens that can drive NK cell diversification? Does 
a diverse NK cell repertoire correspond to a less diverse T and B 
cell repertoire? In addition, most studies have focused only on 
peripheral blood, but tissue-specific functions of NK cells are 
increasingly being appreciated (62).
Together, single-cell studies offer great promise in defining 
the scope of the human NK repertoire and its significance in the 
context of viral infection. This understanding will be essential in 
order to optimally harness the NK cells in the next generation of 
NK cell-based vaccines and therapeutics.
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